Jean Bennett is of REGENXBIO Inc.. Currently has a direct ownership of 11,286 shares of RGNX, which is worth approximately $83,629. The most recent transaction as insider was on May 31, 2024, when has been sold 4,790 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3K
0% 3M change
73.74% 12M change
Total Value Held $83,629

Jean Bennett Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Grant, award, or other acquisition
-
4,790 Added 29.8%
11,286 Common Stock
Jun 02 2023
BUY
Grant, award, or other acquisition
-
3,486 Added 34.92%
6,496 Common Stock
Jun 03 2022
BUY
Grant, award, or other acquisition
-
3,010 Added 50.0%
3,010 Common Stock

Also insider at

OCUP
Ocuphire Pharma, Inc. Healthcare
JB

Jean Bennett

Rockville, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX